Haem: CML and myeloproliferative disorders Pt.2 Flashcards

1
Q

What is primary myelofibrosis?

A
  • A clonal myeloproliferative disease associated with reactive bone marrow fibrosis
  • Characterised by extramedullary haemopoeisis
  • NOTE: other myeloproliferative disorders can transform into myelofibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline the typical presentation of primary myelofibrosis.

A
  • Cytopaenias (anaemia, thrombocytopaenia)
  • Thrombosis
  • MASSIVE splenomegaly
  • Hepatomegaly
  • Hypermetabolic state (FLAWS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What might you expect to see in the blood film of a patient with primary myelofibrosis?

A
  • Leucoerythroblastic picture
  • Tear drop poikilocytes (Dacrocytes)
  • Giant platelets
  • Circulating megakaryocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a characteristic feature seen on bone marrow aspirate in primary myelofibrosis?

A

Dry tap

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What might you see on histological analysis of a trephine biopsy in primary myelofibrosis?

A
  • Increased reticulin and collagen fibrosis
  • Prominent megakaryocyte hyperplasia and clustering
  • New bone formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which mutations would you test for in a patient with primary myelofibrosis?

A

JAK2 and Calreticulin

NOTE: these are not diagnostic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some bad prognostic features in primary myelofibrosis?

A
  • Severe anaemia
  • Thrombocytopaenia
  • Massive splenomegaly

NOTE: median survival is 3-5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline the treatment options for primary myelofibrosis.

A
  • Supportive - RBC and platelet transfusions (usually ineffective becasue of splenomegaly)
  • Hydroxycarbamide (may worsen anaemia)
  • Ruxolitinib - JAK2 inhibitor
  • Allogeneic stem cell transplantation
  • Splenectomy - dangerous operation but may provide symptomatic relief
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What might you expect to see in the FBC of a patient with CML?

A
  • Leucocytosis (MASSIVE)
  • Normal or raised Hb and platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What would you expect to see in abundance in the blood film of a patient with CML?

A
  • Neutrophils
  • Basophils
  • Myelocytes (NOT blasts)

NOTE: myelocytes are immature myeloid cells that are NOT blasts (analogous to reticulocytes for red blood cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Briefly describe the natural history of CML before targeted treatment was available.

A
  • 5-6 years stable phase
  • 6-12 months accelerated phase
  • 3-6 months blasst crisis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the Philadelphia chromosome?

A

CML is caused by a translocation between 9;22 producing a derivative chromosome, 22q, which is called the Philadelphia chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the two genes that make up the fusion gene in the Philadelphia chromosome?

A

Bcr = breakpoint cluster region

Abl = ableson tyrosine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain how the Philedelphia fusion gene results in excessive proliferation of myeloid cells.

A
  • Abl is a tyrosine kinase that drives cell proliferation but is rarely expressed unless the cells are receiving a stimulus to proliferation
  • Bcr is a housekeeping gene that is constitutively active
  • The Bcr-Abl fusion gene means that the tyrosine kinase component is constitutively activated thereby driving cell proliferation in the absence of a stimulus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List some diagnostic techniques used to identify CML and monitor response to treatment.

A
  • FBC and leucocyte count
  • Cytogenetics and detection of Philadelphia chromosome (FISH)
  • RT-PCR to detect and quantify the number of copies of Bcr-Abl fusion transcript

NOTE: RT-PCR transcript % is the most sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some issues associated with 1st generation Bcr-Abl tyrosine kinase inhibitors?

A
  • Some people fail to achieve a complete cytogenetic response
  • Non-compliance
  • Side-effects (fluid retention, pleural effusion)
  • Loss of major molecular response (due to resistance mutations)
17
Q

List some examples of Bcr-Abl tyrosine kinase inhibitors.

A
  • 1st generation: Imatinib
  • 2nd generation: Dasatinib, nilotinib
  • 3rd generation: Bosutinib
18
Q

What are the next steps in treatment if the first-line fails?

A
  • 1st line fails (no complete cytogenetic response at 1 year or initial response is followed by resistance) → switch to 2nd or 3rd generation
  • 2nd line fails (inadequate response or disease progresses to accelerated or blast phase) → allogeneic stem cell transplantation